18F-FDG PET/CT
Showing 1 - 25 of >10,000
Breast Cancer Female, Breast Cancer Recurrent Trial in Drammen (18F-FDG PET/CT)
Recruiting
- Breast Cancer Female
- Breast Cancer Recurrent
- 18F-FDG PET/CT
-
Drammen, NorwayDrammen Hospital - Vestre Viken HF
Feb 17, 2023
Study of 18F-FAPI Applied to Gastrointestinal Cancer
Not yet recruiting
- Gastrointestinal Cancer
- 18F-FAPI and 18F-FDG PET/CT
- (no location specified)
Mar 28, 2023
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
Recruiting
- Malignant Otitis Externa
- 18F-FDG PET/CT
-
Vandoeuvre les Nancy cedex, FranceVerger Antoine
Aug 9, 2023
Role of 18F-FDG PET/CT in Gastric Cancer
Not yet recruiting
- Gastric Cancer
- pet -ct
- (no location specified)
Jan 8, 2023
GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)
Enrolling by invitation
- GEP-NET
- +3 more
-
Copenhagen, DenmarkRigshospitalet
Jan 24, 2023
Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)
Not yet recruiting
- Lobular Breast Carcinoma
- 68Ga-FAPI-46 PET scan
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Jun 27, 2023
Aneurysmal Subarachnoid Haemorrhage Trial in Montpellier (Early dynamic 18F-FDG PET/CT assessment of cerebral glucose uptake)
Recruiting
- Aneurysmal Subarachnoid Haemorrhage
- Early dynamic 18F-FDG PET/CT assessment of cerebral glucose uptake
-
Montpellier, FranceDépartement d'Anesthésie-Réanimation Gui de Chauliac 80 Av Augus
Jan 24, 2023
Cancer Trial (18F-FAPI PET/CT and 18F-FDG PET/CT)
Not yet recruiting
- Cancer
- 18F-FAPI PET/CT and 18F-FDG PET/CT
- (no location specified)
Aug 1, 2022
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the
Not yet recruiting
- Multiple Myeloma
- +2 more
- 18F-fluciclovine injection
- 18F-FDG PET/CT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 31, 2023
SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)
Recruiting
- SSTR2
- +2 more
- 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
May 24, 2023
Lung Tumors, PET-CT Specimen Imager Trial in Ghent (AURA10 Specimen Imager)
Not yet recruiting
- Lung Neoplasms
- PET-CT Specimen Imager
- AURA10 Specimen Imager
-
Ghent, BelgiumUniversity Hospital Ghent
Jan 11, 2023
18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis
Completed
- Diagnostic Self Evaluation
- 18F-FDG
- (no location specified)
Jul 11, 2022
Fluorodeoxyglucose F18 Trial in Ghent (Positron Emissie Tomografie - Computer Tomografie)
Recruiting
- Fluorodeoxyglucose F18
- Positron Emissie Tomografie - Computer Tomografie
-
Ghent, East-flanders, BelgiumUniversity Hospital Ghent
Jan 16, 2023
Stage III NSCLC Trial (18F FDG PET/CT, CT scan)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- 18F FDG PET/CT
- CT scan
- (no location specified)
Oct 9, 2023
Multiple Myeloma Trial in Shenyang (18F-PSMA-1007, 18F-FDG)
Recruiting
- Multiple Myeloma
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Jul 6, 2022
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Computed Tomography
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 3, 2023
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
Aug 8, 2022
Head and Neck Tumors, Thyroid Tumor, Skin Tumor Trial in Ghent (high-resolution PET-CT specimen imaging.)
Completed
- Head and Neck Neoplasms
- +2 more
- high-resolution PET-CT specimen imaging.
-
Ghent, BelgiumGhent University Hospital
Nov 29, 2022
Gastric Cancer, Pancreatic Cancer, Liver Cancer Trial in Xiamen (18F-FDG, 18F-AlF-FAPI PET/CT)
Recruiting
- Gastric Cancer
- +2 more
- 18F-FDG, 18F-AlF-FAPI PET/CT
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
Jun 20, 2022
Muscle-Invasive Bladder Carcinoma, Oligometastatic Disease Trial (metastasis directed therapy (MDT), Immunotherapy)
Recruiting
- Muscle-Invasive Bladder Carcinoma
- Metastasis directed therapy (MDT)
- +2 more
-
Ghent, BelgiumGhent University Hospital
Dec 3, 2022
Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)
Recruiting
- Breast Neoplasms
- +3 more
- 68Ga-FAPI-46 PET/CT
-
Baku, AzerbaijanNational Centre of Oncology
Jun 21, 2022
Factors Affecting BAT Activation in PET/CT
Not yet recruiting
- Factors Affecting BAT Activation in PET/CT
- PET/CT
- (no location specified)
Oct 9, 2022
[18F]-FDG PET/CT and PET/MRI in Lymphomas
Recruiting
- PET/MRI
-
Beijing, Card Holder's Billing State / Province, ChinaPeking University Cancer Hospital
May 22, 2022
Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and
Recruiting
- Breast Cancer
- +4 more
- 18F-FDG PET/CT
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 17, 2023